Comment
doi: 10.1038/nature13503.
Epub 2014 Jun 11.
Cancer: natural-born killers unleashed
Affiliations
- PMID: 24919150
- DOI: 10.1038/nature13503
Item in Clipboard
Comment
Cancer: natural-born killers unleashed
Nature.
.
No abstract available
Comment on
-
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.Nature. 2014 Jun 19;510(7505):407-411. doi: 10.1038/nature13444. Epub 2014 Jun 11. Nature. 2014. PMID: 24919154 Free PMC article.
Similar articles
-
Anticancer drugs: horizons broaden for PI3Kδ inhibitors.Nat Rev Drug Discov. 2014 Aug;13(8):573. doi: 10.1038/nrd4399. Nat Rev Drug Discov. 2014. PMID: 25082283 No abstract available.
-
Immunotherapy: PI3Kδ inhibition lifts the breaks on antitumour immunity.Nat Rev Clin Oncol. 2014 Aug;11(8):442. doi: 10.1038/nrclinonc.2014.112. Epub 2014 Jul 1. Nat Rev Clin Oncol. 2014. PMID: 24981255 No abstract available.
-
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.Nature. 2014 Jun 19;510(7505):407-411. doi: 10.1038/nature13444. Epub 2014 Jun 11. Nature. 2014. PMID: 24919154 Free PMC article.
-
Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.Immunol Invest. 2012;41(6-7):765-97. doi: 10.3109/08820139.2012.689405. Immunol Invest. 2012. PMID: 23017145 Review.
-
Targeting indoleamine 2,3-dioxygenase (IDO) to counteract tumour-induced immune dysfunction: from biochemistry to clinical development.Endocr Metab Immune Disord Drug Targets. 2009 Jun;9(2):151-77. doi: 10.2174/187153009788452453. Endocr Metab Immune Disord Drug Targets. 2009. PMID: 19519465 Review.
Cited by
-
Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.Cancers (Basel). 2018 Feb 16;10(2):51. doi: 10.3390/cancers10020051. Cancers (Basel). 2018. PMID: 29462900 Free PMC article. Review.
-
PI3Kγ inhibition combined with DNA vaccination unleashes a B-cell-dependent antitumor immunity that hampers pancreatic cancer.J Exp Clin Cancer Res. 2024 Jun 1;43(1):157. doi: 10.1186/s13046-024-03080-1. J Exp Clin Cancer Res. 2024. PMID: 38824552 Free PMC article.
-
A Review of Phosphocreatine 3 Kinase δ Subtype (PI3Kδ) and Its Inhibitors in Malignancy.Med Sci Monit. 2021 Oct 9;27:e932772. doi: 10.12659/MSM.932772. Med Sci Monit. 2021. PMID: 34625526 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
